China Probes Glaxo Over Suspected Commercial Bribery GlaxoSmithKline Plc (GSK) executives are suspected of serious commercial bribery and tax-related crimes in China , the government said in the first detailed public disclosure of allegations against the U.K.’s biggest drugmaker.
July 11, 2013 - Bloomberg